Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07533786
PHASE2

A Clinical Trial Evaluating the Efficacy and Safety of HSK55718 in Patients for Postoperative Pain Treatment in Abdominal Surgery

Sponsor: Haisco Pharmaceutical Group Co., Ltd.

View on ClinicalTrials.gov

Summary

This is a multi-center, randomized, double-blind, double-dummy, placebo/active-controlled study. 200 subjects undergoing abdominal surgery under general anesthesia are planned to be enrolled and randomized into the HSK55718 group, morphine group, and placebo group.

Official title: A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo- and Active-Controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of HSK55718 Injection for Postoperative Pain Treatment in Abdominal Surgery

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

200

Start Date

2026-04-20

Completion Date

2027-04-20

Last Updated

2026-04-16

Healthy Volunteers

No

Interventions

DRUG

HSK55718 dose level 1

Patients administrated with HSK55718 at dose level 1

DRUG

HSK55718 dose level 2

Patients administrated with HSK55718 at dose level 2

DRUG

HSK55718 dose level 3

Patients administrated with HSK55718 at dose level 3

DRUG

placebo

Patients administrated with placebo

DRUG

morphine

Patients administrated with morphine

Locations (2)

The Third Xiangya Hospital of Central South University

Changsha, Hunan, China

Sichuan Provincial People's Hospital

Chengdu, Sichuan, China